Xcovery Vision 
Xcovery Vision is developing small molecule kinase inhibitors for opthamology indications. We have 4-5 canidates licensed exclusively to Xcovery Vision from Xcovery for the purpose of developing drugs for several eye diseases.
We are a spin out of Xcovery the parent oncology company founded by Sheridan Snyder founder of Genzyme and Dr. Chris Liang developer of Sutent, Pfizer's leading kidney cancer drug.
We are developing a oral drug for AMD which will be going into a Phase 1B trial this October.
Please visit our website for more information www.xcoveryvision.com
